We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid-Ohio Valley Community.
- Authors
Darrow, Lyndsey A.; Groth, Alyx C.; Winquist, Andrea; Hyeong-Moo Shin; Bartell, Scott M.; Steenland, Kyle
- Abstract
BACKGROUND: Perfluorooctanoic acid (PFOA or C8) has hepatotoxic effects in animals. Crosssectional epidemiologic studies suggest PFOA is associated with liver injury biomarkers. OBJECTIVES: We estimated associations between modeled historical PFOA exposures and liver injury biomarkers and medically validated liver disease. METHODS: Participants completed surveys during 2008-2011 reporting demographic, medical, and residential history information. Self-reported liver disease, including hepatitis, fatty liver, enlarged liver and cirrhosis, was validated with healthcare providers. Alanine aminotransferase (ALT), γ-glutamyltransferase (GGT) and direct bilirubin, markers of liver toxicity, were obtained from blood samples collected in the C8 Health Project (2005-2006). Historically modeled PFOA exposure, estimated using environmental fate and transport models and participant residential histories, was analyzed in relation to liver biomarkers (n = 30,723, including 1,892 workers) and liver disease (n = 32,254, including 3,713 workers). RESULTS: Modeled cumulative serum PFOA was positively associated with ALT levels (p for trend < 0.0001), indicating possible liver toxicity. An increase from the first to the fifth quintile of cumulative PFOA exposure was associated with a 6% increase in ALT levels (95% CI: 4, 8%) and a 16% increased odds of having above-normal ALT (95% CI: odds ratio: 1.02, 1.33%). There was no indication of association with either elevated direct bilirubin or GGT; however, PFOA was associated with decreased direct bilirubin. We observed no evidence of an effect of cumulative exposure (with or without a 10-year lag) on all liver disease (n = 647 cases), nor on enlarged liver, fatty liver, and cirrhosis only (n = 427 cases). CONCLUSION: Results are consistent with previous cross-sectional studies showing association between PFOA and ALT, a marker of hepatocellular damage. We did not observe evidence that PFOA increases the risk of clinically diagnosed liver disease.
- Subjects
PERFLUOROOCTANOIC acid; LIVER abnormalities; LIVER diseases; HEPATOTOXICOLOGY; TOXIC substance exposure; DISEASE risk factors
- Publication
Environmental Health Perspectives, 2016, Vol 124, Issue 8, p1227
- ISSN
0091-6765
- Publication type
Article
- DOI
10.1289/ehp.1510391